Clinical Trial Update: Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of asimadoline (TP0052) for vasomotor symptoms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• Asimadoline (asimadoline)

Snippet

Sponsor: Tioga Pharmaceuticals | Conditions: Vasomotor Symptoms | Phase 2 | Status: RECRUITING